lowtrade

[lowtrade]

RNVA news eval


Don't understand why RNVA's shareholders would think the news is negative. I personally don't see it as negative or positive. But if I had too IMO the CEO taking control of the company is often seen once the business plan starts seeing results.

This 250,000 series J preferred is just a poison pill.

So lets go over the breakdown of the main points of the series J stock, step by step.

1st General the CEO is basically converting $250,000 in company debit to him, into preferred stock worth $1.00 per share. This is good, debit now off the books.

2nd The voting gives the CEO 12,000 share votes per each series J share or 250,000 x 12,000 = 3,000,000,000. This is the poison pill. The CEO has the voting power of the entire A/S. Basically saying I control all business plans.

3rd Conversion the series J value divided by the 10 day Average daily price. Today that would be $1.00 series J share value / .0015 10 day ADV = 666.6 common shares for each series J share. OR 666.6 x 250,000 = 166,666,666 share of common for all series J shares held by the CEO.

As for the mention of a possible increase of authorized or decrease of the outstanding. This pretty much to be expected after the restructuring which took place to achieve the addition of the second hospital.

As a result of conversions and exercises of the Company’s securities, as of July 20, 2018 the Company had 2,344,349,384 shares of common stock issued and outstanding.

The 3 bill A/S has just about been filled already. So to continue to fund the company, it has to restructure again to make room. And IMO a reverse split will be much better then an increase of the A/S to 10 bill.

An A/S increase creates dilution but R/S balances down the OS equal to the share price up. Basically A/S change reduces value and R/S maintains value.